A Single Site, Open-label, Randomized, Single-dose, Two-way Cross-over Study in Healthy Japanese Subjects to Evaluate the Bioequivalence, Safety and Tolerability of Levetiracetam Administered as an Oral Tablet or Intravenous Infusion.

Trial Profile

A Single Site, Open-label, Randomized, Single-dose, Two-way Cross-over Study in Healthy Japanese Subjects to Evaluate the Bioequivalence, Safety and Tolerability of Levetiracetam Administered as an Oral Tablet or Intravenous Infusion.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Levetiracetam (Primary) ; Levetiracetam (Primary)
  • Indications Epilepsy; Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Pharmacokinetics
  • Sponsors UCB
  • Most Recent Events

    • 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top